Compare WD 40 Company (WDFC) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
WD 40 Company vs Health Care Select Sector SPDR Fund — how do they compare? WD 40 Company trades at $237.72 (market cap $3.22B), while Health Care Select Sector SPDR Fund trades at $160.19. The key difference: WD 40 Company pays a 1.7% dividend while Health Care Select Sector SPDR Fund pays none, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, WD 40 Company nearer its low. Which is the better fit depends on your goals.
| WDFC | XLV | |
|---|---|---|
Market Cap | $3.22B | — |
Sector | Technology | — |
52-Week High | $264.91 | $164.48 |
52-Week Low | $187.52 | $129.01 |
Enterprise Value | $3.27B | — |
Dividend Yield | 1.7% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
WDFC trades at $239.59, down 2.92% on the day, with a mixed technical picture showing bullish overall signals but bearish moving averages. The company reported strong Q2 2026 earnings of $2.33 per share, beating estimates, and maintains solid profitability with a 13.22% net income margin. Recent news highlights its brand strength and efficient operations, though some analysts see limited upside.
The outlook is balanced: earnings beats and a strong brand provide support, but high valuation multiples (P/E 36.44) and mixed analyst sentiment (71.42% hold rating) suggest cautious optimism. Key risks include margin pressure from input costs and competitive challenges, requiring careful monitoring of future earnings consistency.
XLV trades at $159.25, down 1.14% with neutral technical signals overall. The healthcare ETF shows mixed momentum with bullish moving averages but neutral oscillators. Recent news highlights XLV's defensive characteristics amid market volatility, with State Street upgrading healthcare to positive for Q3 2026. The fund's diversified approach offers stability compared to more volatile biotech-focused alternatives.
XLV presents a defensive opportunity with lower costs and steady performance, though upside may be limited in the current cycle. Key risks include patent cliff concerns and sector rotation away from defensive plays if market sentiment improves. The ETF's broad healthcare exposure provides cushion against individual stock volatility while benefiting from pipeline innovations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About WD 40 Company
WD-40 Company is a global marketing organization dedicated to creating 'positive lasting memories' by developing and selling products that solve maintenance and cleaning problems. Built around the legendary WD-40 Multi-Use Product, the company operates an asset-light business model, focusing on brand management and innovation while utilizing a network of contract manufacturers to deliver solutions across the Americas, EIMEA, and Asia-Pacific.
Read more on WDFC →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
